Offer - Urjas Oil for just ₹ 1 X
Mabtas T, a prescription drug, is manufactured in various forms such as Injection. Primarily, it is used for the treatment of Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia. Secondary and off-label uses of Mabtas T have also been mentioned below.
The optimal dosage of Mabtas T is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Common side effects of Mabtas T include Weakness. Some other side effects of Mabtas T have been listed ahead. These side effects of Mabtas T are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Mabtas T has a Moderate effect for pregnant women and Severe effect on lactating mothers. Further, the section on Mabtas T related warnings talks about Mabtas T's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Hyperkalemia must refrain from the use of Mabtas T since this can cause severe adverse effects. Other contraindications of Mabtas T have been discussed in the sections ahead.
Additionally, Mabtas T may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Mabtas T is not safe while driving, and is is not addictive in nature.
Mabtas T is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Mabtas T safe for pregnant women?
Pregnant women may experience moderate side effects from Mabtas T. It is best to stop taking Mabtas T immediately and inform your doctor if you notice any discomfort.
Is the use of Mabtas T safe during breastfeeding?
Taking Mabtas T may lead to serious side effects if you are breastfeeding. Mabtas T should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Mabtas T on the Kidneys?
Mabtas T can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Mabtas T on the Liver?
Using Mabtas T does not have any harmful effects on the liver.
What is the effect of Mabtas T on the Heart?
The heart can be affected by Mabtas T. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Mabtas T should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Mabtas T unless your doctor advises you to do so -
Is this Mabtas T habit forming or addictive?
Mabtas T is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Mabtas T. So it is best to avoid driving.
Is it safe?
Mabtas T is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Mabtas T cannot treat any kind of mental disorder.
Interaction between Food and Mabtas T
You can take Mabtas T with food.
Interaction between Alcohol and Mabtas T
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Mabtas T.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rituxan (rituximab)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1106-1109
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872